Compare Boston Scientific Corporation (BSX) vs Rivian Automotive, Inc. (RIVN) Price & Performance

Boston Scientific CorporationTrade

Rivian Automotive, Inc.Trade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Rivian Automotive, Inc. — how do they compare? Boston Scientific Corporation trades at $51.03 (market cap $74.19B), while Rivian Automotive, Inc. trades at $16.45 (market cap $23.69B). The key difference: Boston Scientific Corporation is far larger — about 3.1× Rivian Automotive, Inc.'s market cap, and Rivian Automotive, Inc. is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.

	BSX	RIVN
Market Cap	$74.19B	$23.69B
Sector	Health	Consumer Cyclical
52-Week High	$108.14	$22.45
52-Week Low	$42.63	$11.97
Enterprise Value	$86.27B	$23.73B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

BSX trades at $50.46, up 2.33% today, with strong earnings beats in recent quarters and a bullish technical trend. Revenue grew to $20.07B in 2025, with net income margin expanding to 17.5%. The stock shows robust institutional support and insider buying, while facing near-term headwinds from competitive pressures in key segments like WATCHMAN.

Outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target, implying 33% upside. Risks include guidance cuts and market share losses, but solid cash flow and valuation metrics support long-term growth potential for patient investors.

Rivian Automotive, Inc.

Rivian (RIVN) trades at $16.39, up 2.44% today, showing bullish technical signals with recent price momentum. The company continues to narrow losses, with Q2 2026 EPS beating expectations at -$0.47 versus -$0.66 expected. Revenue growth is steady, reaching $5.39B in 2025, while cash burn remains a key focus as the R2 vehicle ramp-up progresses.

Outlook is cautiously optimistic with analyst consensus price target of $18.70 offering potential upside. Key opportunities include R2 demand and margin improvements, but risks from high cash burn and competitive pressures persist. Execution on profitability targets will be critical for sustained stock appreciation.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BSX

Boston Scientific posts strong Q2 growth despite U.S. challenges, stock now valued attractively.Seeking Alpha · 1 day agoBullish Boston Scientific to present at Wells Fargo Healthcare Conference and report Q3 2026 results in OctoberPRNewsWire · 2 days agoNeutral View details →

RIVN

Rivian CEO details EV expansion and AI integration at TechCrunch Disrupt 2026TechCrunch · 1 day agoBullish Nio shares drop 5% after BlackRock reduces stake despite strong delivery growth.24/7 Wall Street · 1 day agoBearish Rivian raises FY2026 delivery guidance, expects positive Q4 margins and growth in 2027.Seeking Alpha · 3 days agoBullish View details →

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About Rivian Automotive, Inc.

Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.